SightfileU.S. market data from official filings
Companies › CRDL
Cardiol Therapeutics Inc (CRDL)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001702123 · EDGAR filings · Updated 2026-07-14
Cardiol Therapeutics Inc (CRDL) has reported institutional ownership of 27.7%, with 46 institutional managers holding positions valued at $37.5M per the latest 13F reporting period.
Institutional ownership
27.7%
Institutional managers
46
Reported 13F value
$37.5M
Latest updates
- 2026-07-14 — Foreign issuer report (6-K) filed
- 2026-07-09 — Foreign issuer report (6-K) filed
- 2026-06-25 — Foreign issuer report (6-K) filed
- 2026-06-23 — Foreign issuer report (6-K) filed
- 2026-05-26 — Foreign issuer report (6-K) filed
- 2026-05-15 — SCHEDULE 13G/A filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Cardiol Therapeutics Inc has 46 institutional holders and institutional ownership of 27.7%.
Related companies
AARDVARK THERAPEUTICS INC (AARD) · ACTUATE THERAPEUTICS INC (ACTU) · TENAYA THERAPEUTICS INC (TNYA) · BIOMEA FUSION INC (BMEA) · INSPIREMD INC (NSPR) · iBio Inc (IBIO)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-14.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-14.